Global Blood Ketone Meter Market Insights, Forecast to 2028

Global Blood Ketone Meter Market Insights, Forecast to 2028

Market Analysis and Insights: Global Blood Ketone Meter Market

Due to the COVID-19 pandemic, the global Blood Ketone Meter market size is estimated to be worth US$ 328.83 million in 2022 and is forecast to a readjusted size of US$ 553.59 million by 2028 with a CAGR of 9.07% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Non-Smart accounting for 64.57% of the Blood Ketone Meter global market in 2021, is projected to value US$ 349.26 million by 2028, growing at a revised 8.70% CAGR from 2022 to 2028. While Household segment is altered to an 9.51% CAGR throughout this forecast period.

China Blood Ketone Meter market size was US$ 34.49 million in 2021, while the US and Europe Blood Ketone Meter were US$ 113.90 million and US$ 108.07 million, severally. China, India, and Southeast Asia are noteworthy markets in Asia, with CAGR 13.33%, 14.69%, and 14.12% respectively for the next 6-year period. As for the Europe Blood Ketone Meter landscape, Germany is projected to reach US$ 45.14 million by 2028 trailing a CAGR of 10.67% over the forecast period.

The global key manufacturers of Blood Ketone Meter include Abbott, Nova Biomedical, Trividia, Bioland Technology, ACON Laborators, i-Sens, TaiDoc Technology, EKF Diagnostics, and Glucorx, etc. In 2021, the global top five players hold a share approximately 39.89% in terms of revenue.

Global Blood Ketone Meter Scope and Segment

Blood Ketone Meter market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Blood Ketone Meter market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2017-2028.

By Company

Abbott

Nova Biomedical

Trividia

Bioland Technology

ACON Laboratories

i-Sens

TaiDoc Technology

EKF Diagnostics

Glucorx

Lepu Medical Technology

e-LinkCare Meditech

APEX Biotechnology

VivaChek Biotech

Beijingyicheng

Medtrust

Segment by Type

Non-Smart

Smart

Segment by Application

Medical Institutions

Household

Others

Segment by Region

North America

United States

Canada

Asia-Pacific

China

Japan

Korea

India

Southeast Asia

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Middle East & Africa

Turkey

Saudi Arabia

Egypt